Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2010
11/17/2010CN101888999A Pyridylmethyl-sulfonamide compounds
11/17/2010CN101888877A Pyridine derivatives for the treatment of amyloid-related diseases
11/17/2010CN101885722A Heterocycle alkyne and benzene compound, medicinal composition and application thereof
11/17/2010CN101885721A Pyrrole derivatives serving as CCR5 antagonists, method for preparing same and application thereof
11/17/2010CN101370497B Combination product with PARP inhibitors and cell toxin and its uses
11/16/2010US7834187 Crystalline variable hydrate of (S)-6-(4-(2-((3-9H-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarbox amide hemisuccinate salt
11/16/2010US7834186 Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834047 Arylsulfonamides and uses related thereto
11/16/2010US7834043 Prevent reproduct of aids virus
11/16/2010US7834037 5-lipoxygenase-activating protein (FLAP) inhibitors
11/16/2010US7834035 Allosteric modulators of metabotropic glutamate receptors
11/16/2010US7834033 administering a tumor necrosis factor inhibitor; angiogenesis inhibitor; treating inflammatory, and autoimmune diseases
11/16/2010US7834032 Piperidine derivatives
11/16/2010US7834031 18F, 11C, or deuterated fluoromethoxy-substituted 4-phenyl-4-benzoylaminomethylpiperindosulfonyl compounds for diagnostic imaging
11/16/2010US7834025 Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
11/16/2010US7834021 3-aminopyrrolidine derivatives as modulators of chemokine receptors
11/16/2010US7834020 Crystal structure; antidepressants; anxiolytic agents; eating disorders; bipolar disorders; Alzheimer's disease; sleep disorders; psychiatric disorders; sexual dysfunctions; fibromyalgia
11/16/2010US7834016 breast cancer, prostate cancer, and colon cancer; indole, indoline, indol-2-one, or benzimidazoline based compounds having arylamine groups, for example 1-(pyrid-4-ylamino)-4-(2-(indol-3-yl)ethylamino)benzene
11/16/2010US7834011 Heterocyclylalkyl derivatives as novel inhibitors of histone deacetylase
11/16/2010US7834010 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)
11/16/2010US7834007 Calcitonin gene-related peptide (CGRP); migraines; amido- and urea or carbamate functional compounds containing piperidine and one of indazolyl, benzotriazolyl, or benzooxazolin-2-one rings
11/16/2010US7834002 4-amino-5-cyanopyrimidine derivatives
11/16/2010US7834000 CGRP receptor antagonists
11/16/2010US7833999 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide
11/16/2010US7833991 Amine compound and use thereof
11/16/2010US7833632 Nitrogenous heterocycle derivative, and organic electroluminescent element employing the same
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
11/16/2010CA2389165C Substituted indoles for modulating nfkb activity
11/11/2010WO2010129802A1 Inhibitors of jak
11/11/2010WO2010129509A1 Vinyl indazolyl compounds
11/11/2010WO2010129467A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010WO2010129451A1 Process for preparing bromo-substituted quinolines
11/11/2010WO2010128685A1 Alpha helix mimetics and methods relating thereto
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128518A2 Novel process for the preparation of cisatracurium besylate
11/11/2010WO2010128425A1 Gpr 119 modulators
11/11/2010WO2010128414A1 Gpr 119 modulators
11/11/2010WO2010128345A1 Kynurenic acid analogues, pharmaceutical compositions containing same and use of said compounds for the treatment of headache
11/11/2010WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010WO2010127855A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/11/2010WO2010096371A3 Heterocyclic compounds which modulate the cb2 receptor
11/11/2010WO2009016498A8 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
11/11/2010WO2007143597A9 Organic compounds
11/11/2010US20100286400 Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
11/11/2010US20100286397 Salt and crystalline forms thereof of a drug
11/11/2010US20100286391 Novel processes for the preparation of cyclopropyl-amide derivatives
11/11/2010US20100286209 Vinyl indazolyl compounds
11/11/2010US20100286208 Novel polymorph of esomeprazole potassium and process for its preparation
11/11/2010US20100286206 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
11/11/2010US20100286203 Pharmaceutically acceptable salts of 2--2h-indazole-7-carboxamide
11/11/2010US20100286202 New Compounds
11/11/2010US20100286198 Biofilm-Inhibiting Effect and Anti-Infective Activity of N,C- Linked Arylisoquinolines and the Use Thereof
11/11/2010US20100286190 Certain substituted ureas, as modulators of kinase activity
11/11/2010US20100286178 Compounds and uses thereof
11/11/2010US20100286175 2-(Pyridin-2-yl)-pyrimidines and Their Use for Controlling Harmful Fungi
11/11/2010US20100286173 Fungicide hydroximoyl-tetrazole derivatives
11/11/2010US20100286170 (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1-carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating
11/11/2010US20100286166 Compositions for the treatment of hyperphenylalaninemia
11/11/2010US20100286165 Substituted oxindole compounds
11/11/2010US20100286164 Substituted aryl alkylamino-oxy-analogs and uses thereof
11/11/2010US20100286162 Human papilloma virus inhibitors and pharmaceutical compositions containing same
11/11/2010US20100286160 Substituted piperazines as cb1 antagonists
11/11/2010US20100286152 N-phenyl hydrazides as modulators of the ghrelin receptor
11/11/2010US20100286146 Carboxamide compounds and their use as calpain inhibitors
11/11/2010US20100286135 Heterocyclic amide compounds as protein kinase inhibitors
11/11/2010US20100286133 Diacyl indazole derivatives as lipase and phospholipase inhibitors
11/11/2010US20100286122 CGRP Antagonist Salt
11/11/2010US20100286119 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof
11/11/2010US20100286114 Hedgehog pathway antagonists and therapeutic applications thereof
11/11/2010US20100286112 Compounds for the treatment of metabolic disorders
11/11/2010US20100286110 Azetidinyl g-protein coupled receptor agonists
11/11/2010US20100285145 Gpr 119 modulators
11/11/2010US20100284858 Pyrrole end-capped bipyridine assay powder for selective detection of zinc ions and a process for the preparation thereof
11/11/2010CA2764232A1 Novel heterocyclic compounds
11/11/2010CA2761009A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010CA2760535A1 Vinyl indazolyl compounds
11/11/2010CA2760343A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/11/2010CA2759891A1 Gpr 119 modulators
11/11/2010CA2758302A1 Compounds and compositions comprising cdk inhibitors and methods for treatment of cancer
11/11/2010CA2758289A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
11/10/2010EP2248810A1 Method for producing phenoxypyridine derivative
11/10/2010EP2248807A1 N-phenyl-2-pyrimidine-amine derivatives
11/10/2010EP2248806A2 Quinazoline derivatives as tyrosine kinase inhibitors
11/10/2010EP2247584A1 Fused pyridines active as inhibitors of c-met
11/10/2010EP2247579A1 Sulphoximine-substituted quinazoline derivatives as immunomodulators, their preparation and use as medicaments
11/10/2010EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
11/10/2010EP1924574B1 Process for the syntesis of 5-(methyl-1h-imidazol-1-yl)-3-(tri fluorome th yl)-benzeneamine
11/10/2010EP1545525B1 Radiolabeled neurokinin-1 receptor antagonists
11/10/2010CN1989129B A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinicarbox amide hemisuccinate salt
11/10/2010CN1984900B Indole derivatives having piperidine rings
11/10/2010CN1697650B Non-nucleoside reverse transcriptase inhibitors
11/10/2010CN101883764A Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
11/10/2010CN101881733A method for screening triazole monoamine oxidase inhibitor in high throughput way and compound
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101880276A Substituted diazepan compounds as orexin receptor antagonists
11/10/2010CN101880273A Benzo-hexahydric N-heterocyclic derivatives, preparation method and application thereof in medicines
11/10/2010CN101475521B Method for synthesizing acetate of 1-benzhydryl-3-azetidine amidino acetic ester
1 ... 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 ... 1080